Clinical trial
Next-Generation-Sequencing Approach to Neutropenic Sepsis
NCT05815628 is registered in ClinicalTrials.gov with Boris Böll as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Next-Generation-Sequencing Approach to Neutropenic Sepsis
- Lead sponsor
- Boris Böll
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 5, 2024
- Completion date
- November 1, 2026
- Enrollment
- 400 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.